Results 121 to 130 of about 1,092,122 (354)

Correlation of Urinary Soluble CD163 Levels With Disease Activity and Treatment Response in IgA Nephropathy

Kidney International Reports
Introduction: The TESTING trial demonstrated that corticosteroids reduce the risk of kidney failure in patients with IgA nephropathy (IgAN) but increase the risk of serious adverse events.
Jingyi Li, Jicheng Lv, Muh Goet Wong, Sufang Shi, Jincan Zan, Helen Monaghan, Vlado Perkovic, Hong Zhang, Hong Zhang, Vlado Perkovic, Rajiv Agarwal, Sean Barbour, Daniel Cattran, Alan Cass, Tak Mao Chan, John Feehally, Richard Glassock, Michelle A. Hladunewich, Lai Seong Hooi, Meg J. Jardine, Vivekanand Jha, David W. Johnson, Adeera Levin, Zhi-Hong Liu, Jicheng Lv, Helen Monaghan, Heather Reich, Giuseppe Remuzzi, David C. Wheeler, Muh Geot Wong, Mark Woodward, Yangfeng Wu, Minghui Zhao   +32 more
doaj   +1 more source

Prevalence and predisposing factors for fatigue in patients with chronic renal disease undergoing hemodialysis: a cross-sectional study. [PDF]

Sao Paulo Med J, 2023
Burdelis REM, Cruz FJSM.
europepmc   +1 more source

Chronic renal disease and cardiovascular complications: inevitable or preventable? Now is the time for some intervention studies [PDF]

, 1997
Ashley Irish, Leon A. Simons
openalex   +1 more source

A Qualitative Analysis of Patient Perspectives and Preferences in Lupus Management to Guide Lupus Guidelines Development

Arthritis Care &Research, EarlyView.
Objective A patient‐centered approach for chronic disease management, including systemic lupus erythematosus (SLE), aligns treatment with patients’ values and preferences, leading to improved outcomes. This paper summarizes how patient experiences, perspectives, and priorities informed the American College of Rheumatology (ACR) 2024 Lupus Nephritis (LN)
Shivani Garg, Izzy Hartel, Lisa R. Sammaritano, Anca Askanase, Bonnie L. Bermas, Maria Dall'Era, Alí Duarte‐García, Victoria P. Werth, Brad Rovin, Reem A. Mustafa, Amy S. Turner, Bené Williams, Brian L. Ung, Hiya Bhavsar, Monique C. Gore‐Massy, Nahirannette Pulido, Natacha Guerrero, Natalie M. Smith, Wambui Machua, Linda T. Hiraki, Mary Beth Son   +20 more
wiley   +1 more source

Characterizing the Real-World Risks of Kidney Injuries Associated with Chimeric Antigen Receptor T Cell Therapies—Evidence and Safety

Health Data Science
Background: Recently, several cutting-edge experimental studies have directed chimeric antigen receptor (CAR)-T therapies toward specific renal diseases, revealing substantial renal benefits. Prior to widespread implementation of these animal experiments
Jingyu Wang, Tong Xie, Jiawen Peng, Yuemiao Zhang, Hong Zhang   +4 more
doaj   +1 more source

Lab on a Chip Device for Diagnostic Evaluation and Management in Chronic Renal Disease: A Change Promoting Approach in the Patients' Follow Up. [PDF]

Biosensors (Basel), 2023
Borriello M, Tarabella G, D'Angelo P, Liboà A, Barra M, Vurro D, Vurro D, Lombari P, Coppola A, Mazzella E, Perna AF, Ingrosso D.   +11 more
europepmc   +1 more source

Variability in Nonvitamin K Oral Anticoagulant Dose Eligibility and Adjustment According to Renal Formulae and Clinical Outcomes in Patients With Atrial Fibrillation With and Without Chronic Kidney Disease: Insights From ORBIT‐AF II [PDF]

, 2023
Ren Jie Robert Yao, DaJuanicia N. Holmes, Jason G. Andrade, Adeera Levin, Jonathan P. Piccini, Christopher B. Fordyce   +5 more
openalex   +1 more source

Response to allopurinol and febuxostat according to the fractional excretion of urate in men with gout

Arthritis Care &Research, Accepted Article.
Background Body mass index (BMI), glomerular filtration rate (GFR), and pretreatment urate levels have been reported to influence the urate‐lowering response to allopurinol. We investigated whether the fractional excretion of urate (FEUA) also modulates this response and relates to oxypurinol concentrations. We further evaluated its potential influence
Pascal Richette, Anouk Walter‐Petrich, Quang Dinh Nguyen, Matthieu Resche‐Rigon, Quang Huy Dinh Nguyen, Minh Duc Do, Thao Phuong Mai, Tuan Duc Nguyen, Fernando Perez‐Ruiz, Emmanuel Letavernier, Tristan Pascart, Augustin Latourte, Hang Korng Ea, Thomas Bardin   +13 more
wiley   +1 more source

Heterozygous mutations in factor H aggravate pathological damage in a stable IgA deposition model induced by Lactobacillus casei cell wall extract

Frontiers in Immunology
IntroductionActivation of complement through the alternative pathway (AP) has a key role in the pathogenesis of IgA nephropathy (IgAN). We previously showed, by intraperitoneal injection of Lactobacillus casei cell wall extract (LCWE), C57BL/6 mice ...
Jingyi Li, Jingyi Li, Jingyi Li, Jingyi Li, Jingyi Li, Yaping Dong, Yaping Dong, Yaping Dong, Yaping Dong, Yaping Dong, Feifei Chen, Feifei Chen, Feifei Chen, Feifei Chen, Feifei Chen, Hongyu Yang, Hongyu Yang, Hongyu Yang, Hongyu Yang, Hongyu Yang, Pei Chen, Pei Chen, Pei Chen, Pei Chen, Pei Chen, Hongyu Li, Hongyu Li, Hongyu Li, Hongyu Li, Hongyu Li, Sufang Shi, Sufang Shi, Sufang Shi, Sufang Shi, Sufang Shi, Xujie Zhou, Xujie Zhou, Xujie Zhou, Xujie Zhou, Xujie Zhou, Li Zhu, Li Zhu, Li Zhu, Li Zhu, Li Zhu, Yuemiao Zhang, Yuemiao Zhang, Yuemiao Zhang, Yuemiao Zhang, Yuemiao Zhang, Lijun Liu, Lijun Liu, Lijun Liu, Lijun Liu, Lijun Liu, Xinfang Xie, Feng Yu, Jing Jin, Jicheng Lv, Jicheng Lv, Jicheng Lv, Jicheng Lv, Jicheng Lv, Hong Zhang, Hong Zhang, Hong Zhang, Hong Zhang, Hong Zhang   +67 more
doaj   +1 more source

Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Belimumab in Pediatric Patients with Systemic Lupus Erythematosus: A Multicenter, Open‐Label Trial

Arthritis Care &Research, Accepted Article.
Objective This study aimed to characterize the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of subcutaneous belimumab in pediatric patients with active systemic lupus erythematosus (SLE) receiving standard therapy. Methods This single‐arm, multicenter, open‐label trial (GSK study 200908; NCT04179032) used three‐weight‐band ...
Hermine I. Brunner, Jordi Antón, Inmaculada Calvo‐Penadés, Richard Dimelow, Gerd Horneff, Sylvia Kamphuis, Rebecca Marino, Andre van Maurik, Kirsten Minden, Masaaki Mori, Josephine Ocran‐Appiah, Christel Wilkinson, Yuichi Yamasaki, Deepak Assudani, for the Pediatric Rheumatology Collaborative Study Group (PRCSG) and Paediatric Rheumatology International Trials Organisation (PRINTO) network investigators   +14 more
wiley   +1 more source